Related Experiment Video

Updated: Dec 29, 2025

Isolation of Atrial Myocytes from Adult Mice
08:34

Isolation of Atrial Myocytes from Adult Mice

Published on: July 25, 2019

11.3K

Natriuretic peptides: biomarkers for atrial fibrillation management

Alireza Sepehri Shamloo1, Andreas Bollmann2, Nikolaos Dagres2

  • 1Department of Electrophysiology, Leipzig Heart Institute, Heart Center Leipzig at University of Leipzig, Strümpellstrasse 39, 04289, Leipzig, Germany. Sepehria871@gmail.com.

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|February 1, 2020
PubMed

Insights

Natriuretic peptides (NPs) show promise in predicting atrial fibrillation (AF) development, recurrence, and complications. This review explores their role and suggests clinical applications for managing AF patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Arrhythmia Research

Background:

  • Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical practice.
  • Identifying individuals at risk for AF development/recurrence and its complications is a key cardiology focus.
  • Current guidelines do not strongly recommend biomarker use in AF management, despite emerging predictors.

Purpose of the Study:

  • To review the role of natriuretic peptides (NPs) in predicting AF development and recurrence.
  • To examine the utility of NPs in forecasting AF-associated complications.
  • To propose recommendations for integrating NP utilization into clinical AF patient management.

Main Methods:

  • Literature review focusing on natriuretic peptides (NPs) and atrial fibrillation (AF).
  • Analysis of studies investigating NP levels in relation to AF incidence, recurrence, and outcomes.
  • Synthesis of current evidence to inform clinical practice recommendations.

Main Results:

  • Natriuretic peptides (NPs), including B-type NPs (BNPs), are well-established in heart failure management.
  • The predictive value of NPs for AF development, recurrence, and complications is increasingly recognized.
  • Evidence suggests NPs could offer valuable insights beyond their established role in heart failure.

Conclusions:

  • Natriuretic peptides (NPs) hold significant potential as biomarkers for atrial fibrillation (AF) risk stratification.
  • Further research and guideline integration are needed to fully leverage NPs in AF management.
  • Clinical application of NPs may improve patient outcomes by enabling proactive AF management.

Keywords:
Atrial fibrillationB-Type natriuretic peptideBNPBiomarkerNT-ProBNPNatriuretic peptide

More Related Videos

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats05:12

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats

Published on: February 14, 2022

3.6K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.0K

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
476
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
842
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
711
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.7K